Original Image
click to view more

DYMISTA Drug Profile, 2024: DYMISTA (azelastine hydrochloride; fluticasone propionate) drug patents,

by DYMISTA Drug Profile, 2024: DYMISTA (azelastine hydrochloride; fluticasone propionate) drug patents, FDA exclusivity, litigation, sales revenues

$211.60

List Price: $249.00
Save: $37.40 (15%)
add to favourite
  • In Stock - Ship in 24 hours with Free Online tracking.
  • FREE DELIVERY by Tuesday, May 06, 2025
  • 24/24 Online
  • Yes High Speed
  • Yes Protection
Tell-A-Friend
Last update:

Description

DYMISTA Drug Profile, 2024

This report focuses on DYMISTA and covers the following critical aspects of this drug:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • Patent Trial and Appeal Board (PTAB) patent cases
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
  • Raw active pharmaceutical ingredient (API) sources
FREE UPDATE: Send your receipt to DrugPatentWatch within 30 days for a free updat

Last updated on

Product Details

  • Jan 9, 2024 Pub Date:
  • 9798875589034 ISBN-13:
  • 9798875589034 ISBN-10:
  • English Language